Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10585520 | 0.93 | EPHX1 (0.42) | EPHX1 | |
| SCHEMBL1108447 | 0.84 | EPHX1 (0.42) | EPHX1KDM4EGAA | |
| SCHEMBL9619323 | 0.84 | EPHX1 (0.54) | EPHX1 | |
| SCHEMBL9619380 | 0.82 | EPHX1 (0.34) | EPHX1 | |
| Methane SCHEMBL9788186 | 0.82 | EPHX1 (0.41) | EPHX1KDM4EGAA | |
| SCHEMBL3047193 | 0.82 | EPHX1 (0.32) | EPHX1 | |
| SCHEMBL5161498 | 0.81 | EPHX1 (0.39) | EPHX1KDM4EGAA | |
| SCHEMBL4815468 | 0.79 | EPHX1 (0.37) | EPHX1KDM4EGAA | |
| SCHEMBL21283654 | 0.77 | EPHX1 (0.36) | EPHX1KDM4EGAA | |
| SCHEMBL9619426 | 0.77 | EPHX1 (0.37) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1735010-A4 | METHODS, COMPOSITIONS, AND PREPARATIONS FOR DELIVERY OF IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES CO (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20070166384-A1 | Methods , composition and preparations for delivery of immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-19 | — | — | US | disclosed |
| US-20070166384-A1 | Methods , composition and preparations for delivery of immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-19 | — | — | US | disclosed |
| US-20070166384-A1 | Methods , composition and preparations for delivery of immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-19 | — | — | US | disclosed |
| EP-1646673-B1 | (METH)ACRYLIC ACID ESTERS OF MONOALKOXYLATED POLYOLS, AND PRODUCTION THEREOF | BASF AG (DE) | 2007-03-14 | — | — | EP | disclosed |
| EP-1735010-A2 | METHODS, COMPOSITIONS, AND PREPARATIONS FOR DELIVERY OF IMMUNE RESPONSE MODIFIERS | 3M Innovative Properties Company (US) | 2006-12-27 | — | — | EP | disclosed |
| EP-1646673-A1 | (METH)ACRYLIC ACID ESTERS OF MONOALKOXYLATED POLYOLS, AND PRODUCTION THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005110013-A2 | METHODS, COMPOSITIONS, AND PREPARATIONS FOR DELIVERY OF IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005005514-A1 | (METH)ACRYLIC ACID ESTERS OF MONOALKOXYLATED POLYOLS, AND PRODUCTION THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1034204-B1 | ROOM TEMPERATURE CURABLE SILANE TERMINATED AND STABLE WATERBORNE POLYURETHANE DISPERSIONS WHICH CONTAIN FLUORINE AND/OR SILICONE AND LOW SURFACE ENERGY COATINGS PREPARED THEREFROM | MINNESOTA MINING & MFG (US) | 2004-02-11 | — | — | EP | disclosed |
| US-6313335-B1 | Room temperature curable silane terminated and stable waterborne polyurethane dispersions which contain fluorine and/or silicone and low surface energy coatings prepared therefrom | 3M INNOVATIVE PROPERTIES | 2001-11-06 | — | — | US | disclosed |
| EP-1034204-A1 | ROOM TEMPERATURE CURABLE SILANE TERMINATED AND STABLE WATERBORNE POLYURETHANE DISPERSIONS WHICH CONTAIN FLUORINE AND/OR SILICONE AND LOW SURFACE ENERGY COATINGS PREPARED THEREFROM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| WO-1999026992-A1 | ROOM TEMPERATURE CURABLE SILANE TERMINATED AND STABLE WATERBORNE POLYURETHANE DISPERSIONS WHICH CONTAIN FLUORINE AND/OR SILICONE AND LOW SURFACE ENERGY COATINGS PREPARED THEREFROM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-06-03 | — | — | WO | disclosed |
| EP-0247472-B1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID DERIVATIVES | BAYER AG (DE) | 1992-02-12 | — | — | EP | disclosed |
| EP-0247472-A2 | Process for the preparation of carboxylic acid derivatives | BAYER AG (DE) | 1987-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166384-A1 | Methods , composition and preparations for delivery of immune response modifiers | TLR3, MYD88, IFNG | EPHX1 2649/4885KDM4E 3888/4885GAA 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.